nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—BCHE—peripheral nervous system neoplasm	0.807	1	CbGaD
Pancuronium—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0372	0.512	CbGbCtD
Pancuronium—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0355	0.488	CbGbCtD
Pancuronium—Respiratory insufficiency—Tretinoin—peripheral nervous system neoplasm	0.0074	0.0676	CcSEcCtD
Pancuronium—Respiratory insufficiency—Isotretinoin—peripheral nervous system neoplasm	0.0074	0.0676	CcSEcCtD
Pancuronium—Respiratory insufficiency—Alitretinoin—peripheral nervous system neoplasm	0.00561	0.0512	CcSEcCtD
Pancuronium—Pipecuronium—BCHE—peripheral nervous system neoplasm	0.00372	0.706	CrCbGaD
Pancuronium—Redness—Tretinoin—peripheral nervous system neoplasm	0.00331	0.0302	CcSEcCtD
Pancuronium—Redness—Isotretinoin—peripheral nervous system neoplasm	0.00331	0.0302	CcSEcCtD
Pancuronium—Redness—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.0229	CcSEcCtD
Pancuronium—Drug interaction—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.022	CcSEcCtD
Pancuronium—Drug interaction—Tretinoin—peripheral nervous system neoplasm	0.00241	0.022	CcSEcCtD
Pancuronium—Paralysis—Vincristine—peripheral nervous system neoplasm	0.00235	0.0215	CcSEcCtD
Pancuronium—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.00229	0.021	CcSEcCtD
Pancuronium—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.00228	0.0208	CcSEcCtD
Pancuronium—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.0208	CcSEcCtD
Pancuronium—Drug interaction—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.0167	CcSEcCtD
Pancuronium—Drug interaction—Vincristine—peripheral nervous system neoplasm	0.00176	0.0161	CcSEcCtD
Pancuronium—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.0158	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.00169	0.0154	CcSEcCtD
Pancuronium—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.00166	0.0152	CcSEcCtD
Pancuronium—Apnoea—Etoposide—peripheral nervous system neoplasm	0.00156	0.0142	CcSEcCtD
Pancuronium—Vecuronium—ABCB1—peripheral nervous system neoplasm	0.00155	0.294	CrCbGaD
Pancuronium—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00138	0.0126	CcSEcCtD
Pancuronium—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.0126	CcSEcCtD
Pancuronium—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.00136	0.0124	CcSEcCtD
Pancuronium—Redness—Epirubicin—peripheral nervous system neoplasm	0.0011	0.01	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00989	CcSEcCtD
Pancuronium—Paralysis—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00975	CcSEcCtD
Pancuronium—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00955	CcSEcCtD
Pancuronium—Muscular weakness—Vincristine—peripheral nervous system neoplasm	0.00105	0.00955	CcSEcCtD
Pancuronium—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00952	CcSEcCtD
Pancuronium—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00952	CcSEcCtD
Pancuronium—Flushing—Melphalan—peripheral nervous system neoplasm	0.00103	0.00939	CcSEcCtD
Pancuronium—Redness—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00928	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.000992	0.00906	CcSEcCtD
Pancuronium—Paralysis—Doxorubicin—peripheral nervous system neoplasm	0.000987	0.00902	CcSEcCtD
Pancuronium—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000977	0.00893	CcSEcCtD
Pancuronium—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000977	0.00893	CcSEcCtD
Pancuronium—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000852	0.00778	CcSEcCtD
Pancuronium—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.000816	0.00745	CcSEcCtD
Pancuronium—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000804	0.00734	CcSEcCtD
Pancuronium—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000799	0.0073	CcSEcCtD
Pancuronium—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000798	0.00729	CcSEcCtD
Pancuronium—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000798	0.00729	CcSEcCtD
Pancuronium—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00079	0.00721	CcSEcCtD
Pancuronium—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000787	0.00719	CcSEcCtD
Pancuronium—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000778	0.00711	CcSEcCtD
Pancuronium—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000778	0.00711	CcSEcCtD
Pancuronium—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000768	0.00702	CcSEcCtD
Pancuronium—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000745	0.00681	CcSEcCtD
Pancuronium—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000745	0.00681	CcSEcCtD
Pancuronium—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000741	0.00676	CcSEcCtD
Pancuronium—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000736	0.00672	CcSEcCtD
Pancuronium—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.00072	0.00658	CcSEcCtD
Pancuronium—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000673	0.00615	CcSEcCtD
Pancuronium—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000666	0.00608	CcSEcCtD
Pancuronium—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000631	0.00576	CcSEcCtD
Pancuronium—Flushing—Etoposide—peripheral nervous system neoplasm	0.000616	0.00563	CcSEcCtD
Pancuronium—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000604	0.00552	CcSEcCtD
Pancuronium—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000592	0.00541	CcSEcCtD
Pancuronium—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00059	0.00539	CcSEcCtD
Pancuronium—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000588	0.00537	CcSEcCtD
Pancuronium—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000588	0.00537	CcSEcCtD
Pancuronium—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000582	0.00532	CcSEcCtD
Pancuronium—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00058	0.0053	CcSEcCtD
Pancuronium—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.00516	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000556	0.00508	CcSEcCtD
Pancuronium—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000544	0.00497	CcSEcCtD
Pancuronium—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000515	0.0047	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.0047	CcSEcCtD
Pancuronium—Rash—Topotecan—peripheral nervous system neoplasm	0.000507	0.00463	CcSEcCtD
Pancuronium—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000506	0.00463	CcSEcCtD
Pancuronium—Rash—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00459	CcSEcCtD
Pancuronium—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00459	CcSEcCtD
Pancuronium—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000503	0.00459	CcSEcCtD
Pancuronium—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000502	0.00459	CcSEcCtD
Pancuronium—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000502	0.00459	CcSEcCtD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—NF2—peripheral nervous system neoplasm	0.000501	0.0864	CbGpPWpGaD
Pancuronium—Rash—Melphalan—peripheral nervous system neoplasm	0.000496	0.00453	CcSEcCtD
Pancuronium—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000496	0.00453	CcSEcCtD
Pancuronium—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000481	0.0044	CcSEcCtD
Pancuronium—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00048	0.00439	CcSEcCtD
Pancuronium—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000475	0.00434	CcSEcCtD
Pancuronium—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000472	0.00431	CcSEcCtD
Pancuronium—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00046	0.00421	CcSEcCtD
Pancuronium—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.00407	CcSEcCtD
Pancuronium—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000441	0.00403	CcSEcCtD
Pancuronium—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.00401	CcSEcCtD
Pancuronium—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000429	0.00392	CcSEcCtD
Pancuronium—SLC22A2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.000414	0.0714	CbGpPWpGaD
Pancuronium—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.00375	CcSEcCtD
Pancuronium—SLC22A1—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.000386	0.0665	CbGpPWpGaD
Pancuronium—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00348	CcSEcCtD
Pancuronium—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00348	CcSEcCtD
Pancuronium—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000379	0.00347	CcSEcCtD
Pancuronium—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000377	0.0651	CbGpPWpGaD
Pancuronium—Rash—Vincristine—peripheral nervous system neoplasm	0.000367	0.00335	CcSEcCtD
Pancuronium—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000367	0.00335	CcSEcCtD
Pancuronium—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000352	0.0607	CbGpPWpGaD
Pancuronium—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000348	0.00318	CcSEcCtD
Pancuronium—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00316	CcSEcCtD
Pancuronium—Rash—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00297	CcSEcCtD
Pancuronium—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000324	0.00296	CcSEcCtD
Pancuronium—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00296	CcSEcCtD
Pancuronium—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00292	CcSEcCtD
Pancuronium—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.00274	CcSEcCtD
Pancuronium—Rash—Etoposide—peripheral nervous system neoplasm	0.000297	0.00272	CcSEcCtD
Pancuronium—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000297	0.00271	CcSEcCtD
Pancuronium—CHRM3—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000288	0.0497	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000286	0.0492	CbGpPWpGaD
Pancuronium—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00242	CcSEcCtD
Pancuronium—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00236	CcSEcCtD
Pancuronium—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000247	0.00226	CcSEcCtD
Pancuronium—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00224	CcSEcCtD
Pancuronium—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.00218	CcSEcCtD
Pancuronium—SLC22A2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000238	0.041	CbGpPWpGaD
Pancuronium—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00209	CcSEcCtD
Pancuronium—SLC22A1—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000222	0.0382	CbGpPWpGaD
Pancuronium—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00178	CcSEcCtD
Pancuronium—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00165	CcSEcCtD
Pancuronium—Rash—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00152	CcSEcCtD
Pancuronium—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00152	CcSEcCtD
Pancuronium—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00141	CcSEcCtD
Pancuronium—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00141	CcSEcCtD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—PTPN11—peripheral nervous system neoplasm	0.000116	0.0201	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000107	0.0184	CbGpPWpGaD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—ERBB2—peripheral nervous system neoplasm	9.19e-05	0.0159	CbGpPWpGaD
Pancuronium—CHRND—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	7.22e-05	0.0124	CbGpPWpGaD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—NRAS—peripheral nervous system neoplasm	6.99e-05	0.0121	CbGpPWpGaD
Pancuronium—CHRNA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	6.14e-05	0.0106	CbGpPWpGaD
Pancuronium—CHRNA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	5.83e-05	0.0101	CbGpPWpGaD
Pancuronium—CHRND—Neuronal System—BCHE—peripheral nervous system neoplasm	5.53e-05	0.00954	CbGpPWpGaD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—HRAS—peripheral nervous system neoplasm	5.12e-05	0.00882	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	5.1e-05	0.00879	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	5.06e-05	0.00873	CbGpPWpGaD
Pancuronium—CHRNA1—Neuronal System—BCHE—peripheral nervous system neoplasm	4.7e-05	0.00811	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	4.56e-05	0.00787	CbGpPWpGaD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—peripheral nervous system neoplasm	4.52e-05	0.00779	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—BCHE—peripheral nervous system neoplasm	4.47e-05	0.0077	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	4.07e-05	0.00703	CbGpPWpGaD
Pancuronium—CHRM3—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	3.98e-05	0.00687	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.77e-05	0.00649	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.38e-05	0.00582	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.34e-05	0.00577	CbGpPWpGaD
Pancuronium—CHRM3—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	3.2e-05	0.00553	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	3.07e-05	0.00529	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	2.87e-05	0.00496	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	2.81e-05	0.00485	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	2.68e-05	0.00462	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.57e-05	0.00444	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.55e-05	0.00439	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.48e-05	0.00428	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.47e-05	0.00425	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.44e-05	0.00421	CbGpPWpGaD
Pancuronium—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.4e-05	0.00414	CbGpPWpGaD
Pancuronium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.38e-05	0.0041	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	2.29e-05	0.00395	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	2.29e-05	0.00395	CbGpPWpGaD
Pancuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.25e-05	0.00388	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.22e-05	0.00383	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.22e-05	0.00382	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	2.2e-05	0.0038	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.13e-05	0.00368	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.00357	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.07e-05	0.00356	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	2.05e-05	0.00354	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	2.05e-05	0.00353	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.99e-05	0.00343	CbGpPWpGaD
Pancuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	1.92e-05	0.0033	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.91e-05	0.00329	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	1.89e-05	0.00326	CbGpPWpGaD
Pancuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	1.82e-05	0.00314	CbGpPWpGaD
Pancuronium—CHRND—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.69e-05	0.00292	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.68e-05	0.00289	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.65e-05	0.00285	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.52e-05	0.00262	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00259	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.5e-05	0.00258	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.45e-05	0.00251	CbGpPWpGaD
Pancuronium—CHRNA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.44e-05	0.00248	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.44e-05	0.00248	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.4e-05	0.00241	CbGpPWpGaD
Pancuronium—CHRNA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.37e-05	0.00236	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.32e-05	0.00228	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.31e-05	0.00225	CbGpPWpGaD
Pancuronium—CHRND—Neuronal System—HRAS—peripheral nervous system neoplasm	1.3e-05	0.00224	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.29e-05	0.00222	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.27e-05	0.00218	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.25e-05	0.00216	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.25e-05	0.00215	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	1.21e-05	0.00209	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	1.16e-05	0.002	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.16e-05	0.00199	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.14e-05	0.00197	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.14e-05	0.00197	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.13e-05	0.00195	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	1.12e-05	0.00193	CbGpPWpGaD
Pancuronium—CHRNA1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.1e-05	0.0019	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.1e-05	0.0019	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.09e-05	0.00188	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	1.08e-05	0.00187	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.00182	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.05e-05	0.00181	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-05	0.00179	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.01e-05	0.00174	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	1.01e-05	0.00174	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	1e-05	0.00173	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1e-05	0.00173	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1e-05	0.00172	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	9.99e-06	0.00172	CbGpPWpGaD
Pancuronium—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	9.94e-06	0.00171	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.9e-06	0.00171	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	9.68e-06	0.00167	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GNS—peripheral nervous system neoplasm	9.32e-06	0.00161	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	9.31e-06	0.00161	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.23e-06	0.00159	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.14e-06	0.00158	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.08e-06	0.00157	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—NME1—peripheral nervous system neoplasm	8.94e-06	0.00154	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.91e-06	0.00154	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—COX2—peripheral nervous system neoplasm	8.6e-06	0.00148	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.47e-06	0.00146	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.31e-06	0.00143	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.8e-06	0.00134	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.72e-06	0.00133	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.55e-06	0.0013	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	7.49e-06	0.00129	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.47e-06	0.00129	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.4e-06	0.00128	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	7.35e-06	0.00127	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.74e-06	0.00116	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.56e-06	0.00113	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.53e-06	0.00113	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.47e-06	0.00112	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.28e-06	0.00108	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.12e-06	0.00105	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.93e-06	0.00102	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.92e-06	0.00102	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.91e-06	0.00102	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.87e-06	0.00101	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.85e-06	0.00101	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—TH—peripheral nervous system neoplasm	5.84e-06	0.00101	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	5.78e-06	0.000997	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.71e-06	0.000985	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.65e-06	0.000975	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	5.65e-06	0.000974	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.54e-06	0.000956	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.48e-06	0.000945	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.45e-06	0.00094	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.4e-06	0.000931	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.29e-06	0.000912	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	5.21e-06	0.000899	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.19e-06	0.000894	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.17e-06	0.000891	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	5.17e-06	0.000891	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.14e-06	0.000886	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.93e-06	0.00085	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	4.86e-06	0.000838	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	4.81e-06	0.00083	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	4.77e-06	0.000823	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	4.76e-06	0.000822	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	4.67e-06	0.000806	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.55e-06	0.000785	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	4.49e-06	0.000774	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.26e-06	0.000734	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.18e-06	0.00072	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.1e-06	0.000706	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.06e-06	0.000699	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.97e-06	0.000684	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.89e-06	0.000671	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	3.66e-06	0.000632	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.6e-06	0.000622	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.59e-06	0.00062	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.57e-06	0.000615	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.5e-06	0.000604	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.47e-06	0.000598	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.34e-06	0.000576	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.31e-06	0.00057	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.06e-06	0.000528	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.03e-06	0.000523	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.17e-06	0.000374	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.15e-06	0.00037	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.13e-06	0.000367	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.11e-06	0.000364	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.68e-06	0.00029	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.67e-06	0.000287	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.59e-06	0.000273	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-06	0.000271	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.54e-06	0.000266	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.53e-06	0.000263	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.53e-06	0.000263	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.51e-06	0.000261	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.4e-06	0.000241	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.39e-06	0.000239	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	1.29e-06	0.000222	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.28e-06	0.000221	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-06	0.000219	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.19e-06	0.000206	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-06	0.000204	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-06	0.000198	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.07e-06	0.000185	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	9.89e-07	0.000171	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.79e-07	0.000169	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.7e-07	0.000167	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.36e-07	0.000162	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.27e-07	0.00016	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.27e-07	0.000143	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.19e-07	0.000141	CbGpPWpGaD
